免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

PubMed

India's medical device regulatory framework: a decade of transformation, international harmonization, and the road to global competitiveness.

PMID: 42834824 ·

N, e, h, a, , K, a, m, b, l, e, ;, , P, r, a, j, k, t, a, , B, a, l, a, k, s, h, e, ;, , A, t, i, s, h, , V, e, l, h, a, l

学術誌Expert review of medical devices
年
PMID42834824

抄録

India's medical device regulatory landscape has undergone fundamental transformation over the past decade, with the Medical Device Rules (MDR) 2017 establishing the country's first purpose-built, risk-stratified regulatory architecture. This review examines that decade of reform to assess India's progress toward international regulatory harmonization and to identify priorities for further development. This structured narrative review traces legislative and institutional development from the Drug

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。

↑